Berberine Ameliorates Allodynia Induced by Chronic Constriction Injury of the Sciatic Nerve in Rats

Journal of Medicinal Food

Volumn 18, Issue 8, 2015, Pages 909-915

  Kim, Hyun Jee ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

anti inflammatory agents; antioxidants; berberine; hyperalgesia; neuralgia

Indexed keywords

AMITRIPTYLINE; BERBERINE; MALONALDEHYDE; MYELOPEROXIDASE; ANALGESIC AGENT; PEROXIDASE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC CONSTRICTION INJURY; COLD PLATE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; MALE; MECHANICAL STIMULATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE INJURY; STATISTICAL ANALYSIS; VON FREY HAIR STIMULATION TEST; ADVERSE EFFECTS; ANIMAL; COLD; DISEASE MODEL; DRUG EFFECTS; HYPERALGESIA; INJURIES; LIGATION; METABOLISM; NEURALGIA; NOCICEPTION; PAIN THRESHOLD; PATHOPHYSIOLOGY; SCIATIC NERVE; TREATMENT OUTCOME;

RATTUS;

AMITRIPTYLINE; ANALGESICS; ANIMALS; BERBERINE; COLD TEMPERATURE; CONSTRICTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; MALE; MALONDIALDEHYDE; NEURALGIA; PAIN PERCEPTION; PAIN THRESHOLD; PEROXIDASE; RATS; SCIATIC NERVE; TREATMENT OUTCOME;

EID: 84937873492     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.3346     Document Type: Article

References (42)

1. Treede RD, Jensen TS, Campbell JN, et al. : Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-1635.
2. Magrinelli F, Zanette G, Tamburin S: Neuropathic pain: Diagnosis and treatment. Pract Neurol 2013;13:292-307.
3. Baron R, Binder A, Wasner G: Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010;9:807-819.
4. Haraguchi K, Kawamoto A, Isami K, et al. : TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J Neurosci 2012;32:3931-3941.
5. Moalem G, Tracey DJ: Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240-264.
6. Fidanboylu M, Griffiths LA, Flatters SJ: Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS One 2011;6:e25212.
7. Naik AK, Tandan SK, Dudhgaonkar SP, et al. : Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur J Pain 2006;10:573-579.
8. Kulkarni SK, Dhir A: On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 2008;589:163-172.
9. Peng WH, Lo KL, Lee YH, Hung TH, Lin YC: Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci 2007;81:933-938.
10. Kulkarni SK, Dhir A: Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 2010;24:317-324.
11. Kim SO, Kim HJ: Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy. J Med Food 2013;16:511-517.
12. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209.
13. Loria V, Dato I, Graziani F, Biasucci LM: Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008;2008:135625.
14. Lau D, Mollnau H, Eiserich JP, et al. : Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA 2005;102:431-436.
15. Institute of Laboratory Animal Resources (U. S. ): Guide for the Care and Use of Laboratory Animals, 7th edition. National Academy Press, Washington, DC, 1996.
16. Bennett GJ, Xie YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
17. Mehrotra A, Shanbhag R, Chamallamudi MR, Singh VP, Mudgal J: Ameliorative effect of caffeic acid against inflammatory pain in rodents. Eur J Pharmacol 2011;666:80-86.
18. Bergamo P, Fedele E, Balestrieri M, Abrescia P, Ferrara L: Measurement of malondialdehyde levels in food by high-performance liquid chromatography with fluorometric detection. J Agric Food Chem 1998;46:2171-2176.
19. Devor M, Zalkind V: Reversible analgesia, atonia, and loss of consciousness on bilateral intracerebral microinjection of pentobarbital. Pain 2001;94:101-112.
20. Jasmin L, Kohan L, Franssen M, Janni G, Goff JR: The cold plate as a test of nociceptive behaviors: Description and application to the study of chronic neuropathic and inflammatory pain models. Pain 1998;75:367-382.
21. Berrocoso E, Mico JA, Vitton O, et al. : Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain. Eur J Pharmacol 2011;655:46-51.
22. Gomes DA, Pires JR, Zuza EP, et al. : Myeloperoxidase as inflammatory marker of periodontal disease: Experimental study in rats. Immunol Invest 2009;38:117-122.
23. Apel K, Hirt H: Reactive oxygen species: Metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 2004;55: 373-399.
24. Woolf CJ: Dissecting out mechanisms responsible for peripheral neuropathic pain: Implications for diagnosis and therapy. Life Sci 2004;74:2605-2610.
25. DeLeo JA, Yezierski RP: The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001;90:1-6.
26. Kim HK, Park SK, Zhou JL, et al. : Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 2004;111:116-124.
27. Tan EC, Bahrami S, Kozlov AV, et al. : The oxidative response in the chronic constriction injury model of neuropathic pain. J Surg Res 2009;152:84-88.
28. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP: Beneficial effects of raxofelast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in carrageenan-induced pleurisy. Br J Pharmacol 1999;126:407-414.
29. Kuo CL, Chi CW, Liu TY: The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004;203:127-137.
30. Melemedjian OK, Asiedu MN, Tillu DV, et al. : Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol Pain 2011;7:70.
31. Lao-ong T, Chatuphonprasert W, Nemoto N, Jarukamjorn K: Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine. Pharm Biol 2012;50:1007-1012.
32. Xie Z, Zhang J, Wu J, Viollet B, Zou MH: Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 2008;57:3222-3230.
33. Jeong HW, Hsu KC, Lee JW, et al. : Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 2009;296:E955-E964.
34. Sarna LK, Wu N, Hwang SY, Siow YL, O K: Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages. Can J Physiol Pharmacol 2010;88:369-378.
35. Shirwaikar A, Shirwaikar A, Rajendran K, Punitha IS: In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharm Bull 2006;29:1906-1910.
36. Zhu X, Guo X, Mao G, et al. : Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1. Phytother Res 2013;27:417-421.
37. Niederberger E, Geisslinger G: The IKK-NF-kappaB pathway: A source for novel molecular drug targets in pain therapy? FASEB J 2008;22:3432-3442.
38. Ham M, Lee JW, Choi AH, et al. : Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress. Mol Cell Biol 2013;33:2425-2435.
39. van den Berg R, Haenen GR, van den Berg H, Bast A: Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr 2001;86 Suppl 1:S121-S127.
40. Wan X, Chen X, Liu L, et al. : Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFkappaB signaling pathway in rats. PLoS One 2013;8:e59794.
41. Xie X, Chang X, Chen L, et al. : Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Mol Cell Endocrinol 2013;381:56-65.
42. Hu Y, Ehli EA, Hudziak JJ, Davies GE: Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region. Pharmacogenomics J 2012; 12:372-378.